Wolverine Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.83M | Sell |
76,642
-11,126
| -13% | -$275K | ﹤0.01% | 2259 |
|
|
2025
Q2 | $2.12M | Sell |
87,768
-141,627
| -62% | -$3.3M | ﹤0.01% | 1662 |
|
|
2025
Q1 | $5.78M | Sell |
229,395
-82,595
| -26% | -$2.16M | 0.01% | 917 |
|
|
2024
Q4 | $8.24M | Buy |
311,990
+20,394
| +7% | +$553K | 0.01% | 888 |
|
|
2024
Q3 | $8.48M | Sell |
291,596
-126,805
| -30% | -$3.7M | 0.01% | 770 |
|
|
2024
Q2 | $11.7M | Sell |
418,401
-67,185
| -14% | -$1.85M | 0.01% | 574 |
|
|
2024
Q1 | $13.5M | Buy |
485,586
+198,954
| +69% | +$5.52M | 0.01% | 541 |
|
|
2023
Q4 | $8.25M | Buy |
286,632
+125,785
| +78% | +$3.8M | 0.01% | 810 |
|
|
2023
Q3 | $5.34M | Sell |
160,847
-23,078
| -13% | -$816K | 0.01% | 962 |
|
|
2023
Q2 | $6.64M | Buy |
183,925
+174,830
| +1,922% | +$6.8M | 0.01% | 764 |
|
|
2023
Q1 | $367K | Buy |
+9,095
| New | +$393K | ﹤0.01% | 2811 |
|
|
2022
Q4 | – | Sell |
-44,288
| Closed | -$1.96M | – | 4785 |
|
|
2022
Q3 | $1.96M | Sell |
44,288
-130,783
| -75% | -$6.36M | ﹤0.01% | 1430 |
|
|
2022
Q2 | $8.92M | Sell |
175,071
-22,209
| -11% | -$1.13M | 0.01% | 558 |
|
|
2022
Q1 | $10.3M | Buy |
197,280
+163,522
| +484% | +$8.48M | 0.01% | 680 |
|
|
2021
Q4 | $1.97M | Sell |
33,758
-32,646
| -49% | -$1.62M | ﹤0.01% | 1907 |
|
|
2021
Q3 | $2.89M | Sell |
66,404
-160,803
| -71% | -$7.12M | ﹤0.01% | 1762 |
|
|
2021
Q2 | $8.88M | Buy |
227,207
+2,121
| +0.9% | +$82.5K | 0.01% | 757 |
|
|
2021
Q1 | $8.13M | Buy |
225,086
+172,559
| +329% | +$6.13M | 0.01% | 813 |
|
|
2020
Q4 | $1.93M | Buy |
52,527
+17,907
| +52% | +$657K | ﹤0.01% | 1753 |
|
|
2020
Q3 | $1.19M | Sell |
34,620
-108,940
| -76% | -$3.82M | ﹤0.01% | 1917 |
|
|
2020
Q2 | $4.45M | Buy |
143,560
+67,230
| +88% | +$2.28M | 0.01% | 877 |
|
|
2020
Q1 | $2.37M | Sell |
76,330
-399,141
| -84% | -$13.6M | 0.01% | 1217 |
|
|
2019
Q4 | $17.6M | Buy |
475,471
+188,774
| +66% | +$6.72M | 0.04% | 415 |
|
|
2019
Q3 | $9.85M | Buy |
286,697
+182,803
| +176% | +$6.65M | 0.03% | 529 |
|
|
2019
Q2 | $4.27M | Buy |
103,894
+34,228
| +49% | +$1.36M | 0.01% | 993 |
|
|
2019
Q1 | $2.81M | Sell |
69,666
-13,164
| -16% | -$527K | 0.01% | 1263 |
|
|
2018
Q4 | $3.38M | Buy |
82,830
+54,094
| +188% | +$2.25M | 0.01% | 1055 |
|
|
2018
Q3 | $1.2M | Buy |
+28,736
| New | +$1.11M | ﹤0.01% | 2150 |
|
|
2018
Q1 | – | Sell |
-351,507
| Closed | -$12.1M | – | 5665 |
|
|
2017
Q4 | $12.1M | Buy |
351,507
+270,793
| +335% | +$9.23M | 0.04% | 424 |
|
|
2017
Q3 | $2.73M | Sell |
80,714
-46,041
| -36% | -$1.48M | 0.01% | 1134 |
|
|
2017
Q2 | $4.04M | Buy |
126,755
+66,176
| +109% | +$2.09M | 0.02% | 794 |
|
|
2017
Q1 | $1.97M | Buy |
60,579
+11,062
| +22% | +$349K | 0.01% | 1204 |
|
|
2016
Q4 | $1.53M | Sell |
49,517
-75,903
| -61% | -$2.32M | 0.01% | 1547 |
|
|
2016
Q3 | $3.96M | Buy |
+125,420
| New | +$4.19M | 0.02% | 878 |
|
Other funds holding PFE
Wolverine Trading's PFE Position: Q3 2025 in Review
Wolverine Trading reduced its Pfizer (PFE) stake by 13% in Q3 2025, selling an estimated $275K and leaving 76,642 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2259.
Wolverine Trading first reported a position in PFE in Q3 2016 and has held it in 34 quarters since. The position peaked at $17.6M in Q4 2019. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Wolverine Trading held 76,642 shares of Pfizer worth $1.83M as of Q3 2025.
- Wolverine Trading sold 11,126 Pfizer shares in Q3 2025, an estimated $275K.
- Pfizer made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2259 holding.
- Wolverine Trading first reported a position in Pfizer in Q3 2016 and has held it in 34 quarters since.
- Wolverine Trading's Pfizer position peaked at $17.6M in Q4 2019.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.